Single‐Cell Glycomics of the Pancreatic Tumor Microenvironment: Technologies, Glyco‐Immune Checkpoints, and Tumor–Immune Communication
Advanced Biology · 2026-08 · 10 (8)
DOI: 10.1002/adbi.70152 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Biology, online erschienen am 25.08.2026. Verfasst von Dinh Xuan Tuan Anh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, J…. Hauptthemen laut MEDLINE: Glycomics, Tumor Microenvironment, Pancreatic Neoplasms, Single-Cell Analysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Takeda COCKPI-T Funding, JSPS KAKEN, JST NEXUS.
Abstract (Originalsprache)
In this Review, we summarize recent conceptual and technological advances in single‐cell glycomics, with a particular focus on emerging strategies that enable glycan‐resolved analysis of tumor–immune interactions. We highlight single‐cell glycan and RNA sequencing (scGR‐seq), a methodology that converts glycan information into amplifiable nucleic acid signals, enabling simultaneous profiling of transcriptomes and glycomes at the single‐cell level. In parallel, we introduce GlycoChat, a computational framework designed to systematically infer and visualize glycan–lectin interaction networks within the TME. Integrative application of these approaches to pancreatic ductal adenocarcinoma (PDAC) reveals extensive glycan remodeling during epithelial–mesenchymal transition (EMT) and demonstrates that basal‐like PDAC cells selectively reinforce interactions with lectin receptors expressed on innate immune cells, particularly tumor‐associated macrophages. These EMT‐driven glycan–lectin circuits are proposed to transmit immunosuppressive signals within the TME and show a strong association with clinical outcomes. Collectively, these advances highlight glycans as active mediators, rather than solely passive tumor markers of immune regulation, and provide a conceptual framework for understanding and potentially exploiting glycan‐mediated immune regulation in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.
- Ph.D. Program in Human Biology, School of Integrative and Global Majors, University of Tsukuba, Tsukuba, Ibaraki, Japan.
- Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
ORCID-Profile: Dinh Xuan Tuan Anh, Hiroaki Tateno
Förderung
- Takeda COCKPI-T Funding, JSPS KAKEN
- JST NEXUS
Zitieren
APA
Anh, D. X. T., & Tateno, H. (2026). Single‐Cell Glycomics of the Pancreatic Tumor Microenvironment: Technologies, Glyco‐Immune Checkpoints, and Tumor–Immune Communication. Advanced Biology, 10(8). https://doi.org/10.1002/adbi.70152
Vancouver
Anh DXT, Tateno H. Single‐Cell Glycomics of the Pancreatic Tumor Microenvironment: Technologies, Glyco‐Immune Checkpoints, and Tumor–Immune Communication. Advanced Biology. 2026;10(8). doi:10.1002/adbi.70152
BibTeX
@article{Anh2026,
author = {Anh, Dinh Xuan Tuan and Tateno, Hiroaki},
title = {Single‐Cell Glycomics of the Pancreatic Tumor Microenvironment: Technologies, Glyco‐Immune Checkpoints, and Tumor–Immune Communication},
journal = {Advanced Biology},
year = {2026},
volume = {10},
number = {8},
doi = {10.1002/adbi.70152}
}
EUVIMED